Neogen (NEOG) Net Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -1,951.00 |
| Nov 30, 2025 | -2,090.00 |
| Aug 31, 2025 | 286.00 |
| May 31, 2025 | -28,654.00 |
| Feb 28, 2025 | -1,715.00 |
| Nov 30, 2024 | -21,240.00 |
| Aug 31, 2024 | -2,026.00 |
| May 31, 2024 | -1,670.00 |
| Feb 29, 2024 | -1,426.00 |
| Nov 30, 2023 | -1,651.00 |
| Aug 31, 2023 | -1,464.00 |
| May 31, 2023 | -1,392.00 |
| Feb 28, 2023 | -1,372.00 |
| Nov 30, 2022 | -3,522.00 |
| Aug 31, 2022 | -873.00 |
| May 31, 2022 | -196.00 |
| Feb 28, 2022 | -750.00 |
| Nov 30, 2021 | -622.00 |
| Aug 31, 2021 | -7,383.00 |
| May 31, 2021 | -336.00 |
| Feb 28, 2021 | 66.00 |
| Nov 30, 2020 | 233.00 |
| Aug 31, 2020 | 210.00 |
| May 31, 2020 | 299.00 |
| Feb 29, 2020 | 139.00 |
| Nov 30, 2019 | 367.00 |
| Aug 31, 2019 | 127.00 |
| May 31, 2019 | 235.00 |
| Feb 28, 2019 | 281.00 |
| Nov 30, 2018 | 454.00 |
| Aug 31, 2018 | 215.00 |
| May 31, 2018 | -1,988.00 |
| Feb 28, 2018 | 452.00 |
| Nov 30, 2017 | 372.00 |
| Aug 31, 2017 | -80.00 |
| May 31, 2017 | -358.00 |
| Feb 28, 2017 | 12.00 |
| Nov 30, 2016 | 290.00 |
| Aug 31, 2016 | 7,398.00 |
| May 31, 2016 | -488.00 |
| Feb 29, 2016 | -90.00 |
| Nov 30, 2015 | -242.00 |
| Aug 31, 2015 | -116.00 |